The MAXIS NASDAQ100 ETF (Ticker: JP:2631) offers investors an innovative avenue to tap into the dynamic growth and technological prowess of the NASDAQ-100 Index. Designed with a strategic focus on size and style, this ETF provides exposure to 100 of the largest non-financial companies listed on the NASDAQ Stock Market, capturing a broad spectrum of market-leading firms that are at the forefront of innovation. As a total market ETF within a broad-based niche, it aims to deliver comprehensive coverage across various sectors, predominantly technology, consumer services, and healthcare. By investing in this ETF, stakeholders can benefit from diversified access to some of the most influential companies driving global economic trends. With its commitment to mirroring the performance of the NASDAQ-100, the MAXIS NASDAQ100 ETF is an ideal choice for investors seeking to enhance their portfolio with a robust, growth-oriented segment of the market, characterized by potential high returns and exposure to cutting-edge advancements.
MAXIS NASDAQ100 ETF (2631) Fund Flow Chart
MAXIS NASDAQ100 ETF (2631) 1 year Net Flows: 5B
2631 ETF FAQ
What was JP:2631’s price range in the past 12 months?
JP:2631 lowest ETF price was 17500.00 and its highest was 24655.00 in the past 12 months.
What is the AUM of JP:2631?
As of Feb 18, 2025 The AUM of JP:2631 is 29.27B.
Is JP:2631 overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does JP:2631 pay dividends?
JP:2631 does not currently pay dividends.
How many shares outstanding does JP:2631 have?
Currently, no data Available
Which hedge fund is a major shareholder of JP:2631?
Currently, no hedge funds are holding shares in JP:2631